Stockreport

RECELL® System Feasibility Study Results for Treatment of Diabetic Foot Ulcers Presented at 11th Annual Congress of the Japanese Society of Limb Salvage & Podiatric Medicine

AVITA MEDICAL  (AVMXY) 
NASDAQ:AMEX Investor Relations: avitamedical.com/investors
PDF Innovative regenerative technology using patients’ own skin cells significantly reduced size of wounds caused by diabetic foot ulcers in all patients VALENCIA, Calif. [Read more]